Posts Tagged ‘ISCI’
Early Study Finds MGC018 Active in Resistant Skin Cancer
Sekwon Jang, MD in medical oncology at Inova Schar Cancer Institute, presented the latest data on the multi-institutional Phase 1 clinical trial for MGC018 at the annual American Society of Clinical Oncology held June 4–8, 2021. What is MGC018? MGC018 is an investigational drug developed by MacroGenics that is being studied for the treatment of…
Read MoreColorectal Cancer Screening Should Begin at Age 45
Arthur Winer, MD, is a specialty care physician at Inova Schar Cancer Institute. Dr. Winer is board-certified in internal medicine, hematology and medical oncology. He is a practicing gastrointestinal medical oncologist and has clinical interests in colorectal, esophageal, gastrointestinal, liver and pancreatic cancers. For decades, experts advised people to begin colorectal cancer screening at age…
Read MoreIs Radiation Necessary After Breast Cancer Surgery?
Ductal carcinoma in situ (DCIS) is a cancer that forms in the cells that line the milk ducts, and it accounts for 20% of new breast cancer diagnoses. The most common treatment is breast-conserving surgery to remove the cancerous tissue. While only a small percentage of women experience an invasive cancer event following surgery, radiation…
Read MoreDiet and Exercise Guidelines for Cancer Prevention: How to Get Started
Lauren Fay, RD, CSO, CNSC, is a registered dietitian at the Inova Schar Cancer Institute and Life With Cancer. She is board-certified in oncology nutrition and nutrition support. The American Cancer Society (ACS) recently released new diet and activity guidelines to reduce cancer risk. Great, you might be thinking. One more thing I should be…
Read MoreInova Schar Cancer Institute Announces Plans to Open Cancer Screening and Prevention Center
Falls Church, VA – Inova Health System and its Inova Schar Cancer Institute today announced plans to open a new cancer screening and prevention center on the campus of the Inova Center for Personalized Health. The new 24,000 square-foot center, slated to open in 2022, is being made possible by the generous donation of $20…
Read MoreThe Evolving Role of Immunotherapy for Gastrointestinal Cancers
Raymond Wadlow, MD, is an oncologist at Inova Schar Cancer Institute. He is board-certified in Medical Oncology and Internal Medicine and has a special interest in gastrointestinal oncology. Immunotherapy is a relatively new type of cancer therapy — and for some cancers, it has been a game changer. Unfortunately, it’s been a bumpier road for…
Read MoreLaura Matthews, MBA, MPH Named as Vice President and Administrator of Inova Schar Cancer
Inova Schar Cancer is proud to announce that Laura Matthews, MBA, MPH, has been named as Inova Schar’s Vice President and Administrator. Laura joined Inova in 2014 as part of the strategic planning team before joining the Inova Schar team as Director of Operations and Growth in January 2018. She began working as the Acting Vice…
Read MoreBrain Tumor Treatment Guidelines Feature Inova Co-Author Dr. Mateo Ziu
Dr. Mateo Ziu, medical director of the Inova Brain and Spine Tumor Program and medical director of neuro-oncology at Inova Schar Cancer, was a senior author on the recent article Urgent considerations for the neuro-oncologic treatment of patients with gliomas during the COVID-19 pandemic. The piece contains professional guidelines for implementing a proactive and coordinated…
Read MoreInova Schar Cancer Institute Treats First Patient using Proton Therapy in Northern Virginia
The Inova Mather Proton Therapy Center Opened to Patients on March 9 March 26, 2020, Fairfax, Virginia – On March 26, a local cancer patient was the first to complete proton therapy treatment in Northern Virginia at the Inova Mather Proton Therapy Center in Fairfax. Located at the Inova Schar Cancer Institute, a department of…
Read MoreDealing with Disparities: African American Men and Prostate Cancer
Why prostate cancer is a growing issue among black men February is Cancer Prevention Month. According to new research from the American Cancer Society, black men are more likely to develop prostate cancer in their lifetime than men of other races. With insight from Jeanny Aragon-Ching, MD, Clinical Program Director of Genitourinary Cancers at the…
Read More